Elevated plasma copeptin is independently associated with NAFLD in a population with mixed ethnicities, pointing at the pharmacologically modifiable vasopressin system as a new mechanism behind NAFLD. Here, AVP is linked to metabolic dysfunction-associated steatotic liver disease.